Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases
Clinical trial NCT07481799 · RECRUITING
Trial details
- NCT number
- NCT07481799
- Sponsor
- Ming-Yuan Chen
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2029-02-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.